Amgen reported $143.27B in Market Capitalization for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 190.99B 1.86B
Acceleron Pharma XLRN:US $ 8.22B 514.54M
Agios Pharmaceuticals AGIO:US $ 3.61B 602.58M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Amgen AMGN:US $ 143.27B 9.41B
Astrazeneca AZN:US 131.09B 366.04M
Biogen BIIB:US $ 42.62B 4.94B
Biomarin Pharmaceutical BMRN:US $ 13.79B 2.12B
Bluebird Bio BLUE:US $ 2.02B 847.67M
Bristol Myers Squibb BMY:US $ 140.96B 787.04M
Coherus Biosciences CHRS:US $ 1.07B 184.09M
Dicerna Pharmaceuticals DRNA:US $ 1.95B 298.29M
Eli Lilly And LLY:US $ 179.16B 17.65B
Exelixis EXEL:US $ 7.07B 846.28M
Genmab GEN:DC 136.79B 24.65B
Gilead Sciences GILD:US $ 81.37B 8.34B
GlaxoSmithKline GSK:LN 64.8B 2.7B
Glaxosmithkline GSK:US 89.29B 3B
Intercept Pharmaceuticals ICPT:US $ 762M 53.49M
Johnson & Johnson JNJ:US $ 432685.32M 18375.76M
Merk MRK:US $ 195137.94M 11818.88M
Mirati Therapeutics MRTX:US $ 8.79B 2.25B
Moderna Inc MRNA:US $ 52.4B 11.06B
Neurocrine Biosciences NBIX:US $ 9.19B 238.42M
Novartis NOVN:VX 199.26B 7.11B
Novartis NVS:US 211.22B 23.03B
Pfizer PFE:US $ 202096.88M 2565.35M
Ptc Therapeutics PTCT:US $ 3.33B 834.67M
Puma Biotechnology PBYI:US $ 391.31M 16.65M
Regeneron Pharmaceuticals REGN:US $ 50.69B 862.48M
Sanofi SAN:FP 106.07B 6.99B
Sarepta Therapeutics SRPT:US $ 5.92B 7.53B
Seattle Genetics SGEN:US $ 25.18B 6.4B
Takeda 4502:JP 6281.91B 362.57B
Teva Pharmaceutical TEVA:IT 41.88B 8.4B
Ultragenyx Pharmaceutical RARE:US $ 7.62B 1.5B
Vertex Pharmaceuticals VRTX:US $ 55.62B 5.84B
YTE INCY:US $ 17.87B 1.18B